###begin article-title 0
###xml 94 95 94 95 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fn" rid="fn1">*</xref>
Bioactivation of Nitroglycerin by Purified Mitochondrial and Cytosolic Aldehyde Dehydrogenases*
###end article-title 0
###begin p 1
###xml 211 228 211 228 <email xmlns:xlink="http://www.w3.org/1999/xlink">mayer@uni-graz.at</email>
 To whom correspondence should be addressed: Dept. of Pharmacology and Toxicology, Karl-Franzens-Universitat Graz, Universitatsplatz 2, A-8010 Graz, Austria. Tel.: 43-316-380-5567; Fax: 43-316-380-9890; E-mail: mayer@uni-graz.at.
###end p 1
###begin p 2
###xml 0 15 0 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Author's Choice</italic>
Author's Choice
###end p 2
###begin p 3
 applies to Author Choice Articles
###end p 3
###begin p 4
###xml 1240 1242 1240 1242 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50</sub>
###xml 1282 1283 1277 1278 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 950 956 <span type="species:ncbi:9913">bovine</span>
Metabolism of nitroglycerin (GTN) to 1,2-glycerol dinitrate (GDN) and nitrite by mitochondrial aldehyde dehydrogenase (ALDH2) is essentially involved in GTN bioactivation resulting in cyclic GMP-mediated vascular relaxation. The link between nitrite formation and activation of soluble guanylate cyclase (sGC) is still unclear. To test the hypothesis that the ALDH2 reaction is sufficient for GTN bioactivation, we measured GTN-induced formation of cGMP by purified sGC in the presence of purified ALDH2 and used a Clark-type electrode to probe for nitric oxide (NO) formation. In addition, we studied whether GTN bioactivation is a specific feature of ALDH2 or is also catalyzed by the cytosolic isoform (ALDH1). Purified ALDH1 and ALDH2 metabolized GTN to 1,2- and 1,3-GDN with predominant formation of the 1,2-isomer that was inhibited by chloral hydrate (ALDH1 and ALDH2) and daidzin (ALDH2). GTN had no effect on sGC activity in the presence of bovine serum albumin but caused pronounced cGMP accumulation in the presence of ALDH1 or ALDH2. The effects of the ALDH isoforms were dependent on the amount of added protein and, like 1,2-GDN formation, were sensitive to ALDH inhibitors. GTN caused biphasic sGC activation with apparent EC50 values of 42 +/- 2.9 and 3.1 +/- 0.4 mum in the presence of ALDH1 and ALDH2, respectively. Incubation of ALDH1 or ALDH2 with GTN resulted in sustained, chloral hydrate-sensitive formation of NO. These data may explain the coupling of ALDH2-catalyzed GTN metabolism to sGC activation in vascular smooth muscle.
###end p 4
###begin p 5
###xml 0 15 0 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Author's Choice</italic>
Author's Choice-Final version full access.
###end p 5
###begin p 6
###xml 34 41 34 41 <grant-num xmlns:xlink="http://www.w3.org/1999/xlink">W901 DK</grant-num>
###xml 41 61 41 61 <grant-sponsor xmlns:xlink="http://www.w3.org/1999/xlink">Molecular Enzymology</grant-sponsor>
###xml 63 69 63 69 <grant-num xmlns:xlink="http://www.w3.org/1999/xlink">P16690</grant-num>
###xml 75 81 75 81 <grant-num xmlns:xlink="http://www.w3.org/1999/xlink">P20669</grant-num>
###xml 91 153 91 153 <grant-sponsor xmlns:xlink="http://www.w3.org/1999/xlink">Fonds zur F&#246;derung der Wissenschaftlichen Forschung in Austria</grant-sponsor>
###xml 166 197 166 197 <grant-sponsor xmlns:xlink="http://www.w3.org/1999/xlink">Deutsche Forschungsgemeinschaft</grant-sponsor>
###xml 204 214 204 214 <grant-num xmlns:xlink="http://www.w3.org/1999/xlink">KO1157/4-1</grant-num>
###xml 245 284 245 284 <grant-sponsor xmlns:xlink="http://www.w3.org/1999/xlink">Endowment for Research in Human Biology</grant-sponsor>
###xml 464 477 464 477 <italic xmlns:xlink="http://www.w3.org/1999/xlink">advertisement</italic>
###xml 271 276 <span type="species:ncbi:9606">Human</span>
This work was supported by Grants W901 DKMolecular Enzymology, P16690, and P20669 from the Fonds zur Foderung der Wissenschaftlichen Forschung in Austria (to B. M.), Deutsche Forschungsgemeinschaft Grant KO1157/4-1 (to D. K. and M. R.), and the Endowment for Research in Human Biology, Boston, Massachusetts (to W. M. K.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
###end p 6
###begin p 7
###xml 40 41 40 41 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fn" rid="fn2">2</xref>
###xml 149 150 149 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref1">1</xref>
###xml 329 330 329 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref2">2</xref>
###xml 465 466 465 466 <sc xmlns:xlink="http://www.w3.org/1999/xlink">l</sc>
###xml 548 549 548 549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref3">3</xref>
###xml 802 803 802 803 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref4">4</xref>
The antianginal drug nitroglycerin (GTN)2 causes vasodilation through NO-mediated activation of sGC and cGMP accumulation in vascular smooth muscle (1). In virtually all cells and tissues, the slow reaction of GTN with thiols, in particular GSH, yields 1,2- and 1,3-GDN together with stoichiometric amounts of inorganic nitrite (2), but thiol-triggered GTN metabolism is not associated with GTN bioactivation except the still poorly understood reaction of GTN with l-cysteine that leads to formation of a bioactive species with NO-like properties (3). Recently we have identified ascorbate as another endogenous reductant that causes non-enzymatic GTN bioactivation, but the reaction is slow and may not contribute significantly to the hemodynamic effects of GTN under normal physiological conditions (4).
###end p 7
###begin p 8
###xml 226 227 226 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref1">1</xref>
###xml 421 422 421 422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref5">5</xref>
###xml 791 792 791 792 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref6">6</xref>
###xml 793 795 793 795 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref10">10</xref>
###xml 1111 1113 1111 1113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref11">11</xref>
###xml 1103 1109 <span type="species:ncbi:9606">humans</span>
Besides these non-enzymatic reactions, a number of enzymatic pathways catalyzing GTN bioactivation have been described, but it has remained unclear whether there is a distinct enzyme that mediates the vascular effects of GTN (1). Several years ago, ALDH2 (mitochondrial aldehyde dehydrogenase, EC 1.2.1.3), the main mitochondrial isoform of the ALDH superfamily, was proposed as a new candidate to fulfill this function (5). The characteristics of ALDH2-catalyzed GTN metabolism, including relatively high GTN affinity (low micromolar) and selective formation of 1,2-GDN, rendered this pathway very promising, and several laboratories reported that pharmacological inhibition or gene deletion of ALDH2 led to significantly impaired GTN-induced vasorelaxation and vascular cGMP accumulation (6-10). In addition, treatment of volunteers with an ALDH inhibitor attenuated the increase in forearm blood flow caused by GTN infusion to a similar degree as observed in East Asian subjects expressing a low activity mutant of ALDH2, indicating that this pathway contributes to the hemodynamic effects of GTN in humans (11).
###end p 8
###begin p 9
###xml 73 75 73 75 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref12">12</xref>
###xml 76 78 76 78 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref14">14</xref>
###xml 256 257 256 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref5">5</xref>
###xml 285 287 285 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref14">14</xref>
###xml 712 713 712 713 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref5">5</xref>
###xml 715 716 715 716 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref9">9</xref>
###xml 979 981 979 981 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref15">15</xref>
###xml 1351 1355 1351 1355 <italic xmlns:xlink="http://www.w3.org/1999/xlink">i.e.</italic>
###xml 1463 1465 1463 1465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref16">16</xref>
There are three early reports on inhibition of ALDH by organic nitrates (12-14), but the pharmacological implication of these observations had not been considered before the discovery of ALDH2-catalyzed GTN bioactivation by the Stamler laboratory in 2002 (5). Mukerjee and Pietruszko (14) showed that the cytosolic and mitochondrial ALDH isoforms are inactivated by isosorbide dinitrate in a mechanism-based manner, whereby the reversibility of enzyme inactivation by 2-mercaptoethanol suggested the involvement of sulfhydryl oxidation. Later studies confirmed and extended these observations, showing that the presence of a reductant is essential for sustained ALDH2-catalyzed GTN metabolism and bioactivation (5, 9). Intriguingly, the most abundant cellular reductant, GSH, is ineffective, raising the question for the identity of the physiological reductant. A promising candidate is dihydrolipoic acid, which was shown to restore ALDH2 activity in GTN-exposed blood vessels (15). However, enzyme reactivation required relatively high concentrations of the reductant, and evidence for a role of endogenous dihydrolipoic acid in GTN bioactivation is still missing. This issue is of considerable pharmacological interest because vascular depletion of the endogenous ALDH2 reductant may at least partially explain the phenomenon of nitrate tolerance, i.e. the loss of vascular sensitivity to GTN upon continuous application because of impaired GTN bioactivation (16).
###end p 9
###begin p 10
###xml 375 377 375 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref17">17</xref>
###xml 533 535 533 535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref18">18</xref>
###xml 578 579 578 579 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c</italic>
###xml 589 591 589 591 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref19">19</xref>
###xml 741 742 741 742 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fn" rid="fn3">3</xref>
###xml 950 951 950 951 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref9">9</xref>
###xml 1575 1582 1575 1582 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
Notwithstanding the large body of evidence for a significant contribution of ALDH2 to vascular GTN bioactivation, it is still unclear how the ALDH2 reaction, yielding inorganic nitrite as final product, is linked to sGC activation. One possibility would be that nitrite formation is coupled to a nitrite reductase pathway associated with the mitochondrial respiratory chain (17). In support of this hypothesis, isolated mitochondria were found to reduce nitrite to NO in the presence of respiratory substrates at low oxygen tension (18), presumably via activation of cytochrome c oxidase (19). In a recent study we confirmed these observations but found no correlation between mitochondrial respiratory rate and GTN-triggered sGC activation,3 indicating that mitochondrial nitrite reduction is not essential for GTN bioactivation to occur. In search of alternative pathways, we have suggested that ALDH2 itself may catalyze formation of NO from GTN (9). However, this proposal was based on preliminary data and has not been seriously considered by others so far. Therefore, we carried out a detailed study to see whether GTN metabolism catalyzed by purified ALDH2 does indeed result in NO formation and activation of sGC. In addition, we wished to clarify whether the ability to catalyze GTN bioactivation is a specific feature of ALDH2. Interestingly, we found that both ALDH1 (cytosolic aldehyde dehydrogenase, ALDH1A1, EC 1.2.1.36) and ALDH2 are able to convert GTN to NO, although low GTN affinity of ALDH1 may limit the contribution of this isoform to GTN bioactivation in vivo.
###end p 10
###begin title 11
EXPERIMENTAL PROCEDURES
###end title 11
###begin p 12
###xml 0 9 0 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Materials</italic>
###xml 64 66 64 66 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref20">20</xref>
###xml 99 101 95 97 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 278 279 272 273 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 292 293 286 287 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 366 367 360 361 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 522 523 516 517 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 558 559 552 553 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 641 642 635 636 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 768 770 762 764 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref21">21</xref>
###xml 811 813 805 807 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref22">22</xref>
###xml 836 837 830 831 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 877 878 870 871 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 10 16 <span type="species:ncbi:9913">Bovine</span>
###xml 694 700 <span type="species:ncbi:9913">bovine</span>
Materials-Bovine lung sGC was purified as described previously (20). Sephacryl S-300 HR and [alpha-32P]GTP (400 Ci/mmol) were obtained from GE Healthcare Europe GmbH (Vienna, Austria). Nitropohl(R) ampoules (G. Pohl-Boskamp GmbH. & Co., Hohenlockstedt, Germany) containing 4.4 mm GTN in 250 mm glucose were obtained from a local pharmacy; dilutions were made in 50 mm triethanolamine HCl buffer. DEA/NO and ODQ (Alexis Corp., Lausen, Switzerland) were purchased via Eubio (Vienna). DEA/NO was dissolved and diluted in 10 mm NaOH. Stock solutions of ODQ (10 mm) were prepared in dimethyl sulfoxide and diluted with 25% dimethyl sulfoxide in H2O (v/v). Oxyhemoglobin was prepared by reduction of bovine hemoglobin (Sigma) with sodium dithionite as described previously (21). Daidzin was synthesized as described (22) and dissolved in 50 mm triethanolamine HCl at maximally 160 mum (because of limited solubility). All other chemicals were from Sigma-Aldrich GmbH (Vienna).
###end p 12
###begin p 13
###xml 0 32 0 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ALDH Expression and Purification</italic>
###xml 79 95 79 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli</italic>
###xml 131 133 131 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref23">23</xref>
###xml 205 206 205 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 265 267 265 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref24">24</xref>
###xml 428 429 428 429 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 466 467 466 467 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 472 473 472 473 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 33 38 <span type="species:ncbi:9606">Human</span>
###xml 79 100 <span type="species:ncbi:511693">Escherichia coli BL21</span>
ALDH Expression and Purification-Human liver ALDH1 and ALDH2 were expressed in Escherichia coli BL21(DE3) as described previously (23), using pT7.7 as the host vector for both cDNAs. ALDH2 was purified by p-hydroxyacetophenone affinity chromatography as described (24). For final purification, the protein was loaded on a size-exclusion chromatography column (Sephacryl S-300; 100 x 2.5 cm), which had been equilibrated in 100 mm MES buffer (pH 6.5) containing 0.2 mm MgCl2, and eluted with the same buffer at 1 ml/min.
###end p 13
###begin p 14
###xml 141 142 141 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 208 209 208 209 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 246 247 246 247 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 252 253 252 253 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 261 262 261 262 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
ALDH1 was purified according to the same protocol but without the final size-exclusion chromatography step. Active fractions eluted from the p-hydroxyacetophenone column were pooled and dialyzed against 100 mm MES buffer (pH 6.5) containing 0.2 mm MgCl2 and 1 mm DTT.
###end p 14
###begin p 15
###xml 0 50 0 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Determination of ALDH Activity and Enzyme Kinetics</italic>
###xml 107 108 107 108 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 226 229 220 223 <sub xmlns:xlink="http://www.w3.org/1999/xlink">340</sub>
###xml 238 239 232 233 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 239 241 233 235 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;1</sup>
###xml 244 246 238 240 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;1</sup>
###xml 264 266 252 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref25">25</xref>
###xml 316 317 304 305 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 354 355 342 343 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 392 393 380 381 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 398 399 386 387 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 433 435 421 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref26">26</xref>
###xml 457 459 445 447 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 697 699 661 663 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 781 782 745 746 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 829 830 793 794 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 859 862 817 820 <sub xmlns:xlink="http://www.w3.org/1999/xlink">400</sub>
###xml 869 870 827 828 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 870 872 828 830 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;1</sup>
###xml 875 877 833 835 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;1</sup>
###xml 903 904 861 862 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
Determination of ALDH Activity and Enzyme Kinetics-ALDH activity was measured as formation of NADH from NAD+ in the presence of varying concentrations of acetaldehyde by monitoring the increase in absorbance at 340 nm (epsilon340 = 6.22 mm-1 cm-1) at 25 degreesC (25). The incubation buffer (pH 9.0) was either 100 mm sodium pyrophosphate (ALDH1) or 50 mm sodium pyrophosphate containing 10 mm MgCl2 (ALDH2). As reported previously (26), we observed that Mg2+ ions slightly reduced the dehydrogenase activity of ALDH1 (by approximately20%) but increased the respective activity of ALDH2 (by approximately20%). The esterase activities of both isoforms were increased by 20-30% in the presence of Mg2+ ions (data not shown). Esterase activity was measured by monitoring formation of p-nitrophenolate from varying concentrations of p-nitrophenyl acetate (epsilon400 = 16 mm-1 cm-1) in the presence of 100 mm sodium pyrophosphate buffer (pH 7.5). The other ingredients were the same as described for determination of dehydrogenase activity. Enzyme kinetic parameters were calculated by fitting the data according to saturation kinetics using the Kaleidagraph(R) software.
###end p 15
###begin p 16
###xml 0 78 0 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Determination of 1,2- and 1,3-GDN Formation by Radio Thin Layer Chromatography</italic>
###xml 182 183 182 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref9">9</xref>
###xml 254 256 253 255 <sup xmlns:xlink="http://www.w3.org/1999/xlink">14</sup>
###xml 275 276 273 274 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 365 366 344 345 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 407 408 386 387 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 413 414 392 393 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 419 420 398 399 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 429 430 408 409 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 439 440 418 419 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 444 445 423 424 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 450 451 429 430 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 461 462 440 441 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 666 667 643 644 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
Determination of 1,2- and 1,3-GDN Formation by Radio Thin Layer Chromatography-The rate of GTN metabolism yielding 1,2- and 1,3-GDN was determined according to a described protocol (9). Briefly, purified ALDH1 or ALDH2 (4 mug of each) was incubated with 14C-labeled GTN (2 mum; approximately50,000 dpm) at 37 degreesC for 10 min in a final volume of 200 mul of 50 mm phosphate buffer (pH 7.4) containing 3 mm MgCl2, 2 mm GSH, 2 mm DTT, 1 mm NAD+, 1 mm EDTA, 1 mm EGTA, and unlabeled GTN as required to obtain the indicated final concentrations. The amount of added radioactivity was increased 3-fold for determination of reaction rates at GTN concentrations >/=0.3 mm. Enzyme inhibitors (chloral hydrate and the ALDH2-selective compound daidzin) were present as indicated in the text and figure legends. Reaction products were extracted twice with 1 ml of diethyl ether, separated by thin layer chromatography, and quantified by liquid scintillation counting. Blank values were determined in the absence of protein under identical conditions and subtracted. Results are expressed as nmol of product per min and mg of protein. Mean values +/- S.E. were calculated from reaction rates measured as duplicates in three independent experiments.
###end p 16
###begin p 17
###xml 0 29 0 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Determination of sGC Activity</italic>
###xml 195 196 188 189 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 346 347 339 340 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 381 382 374 375 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 387 388 380 381 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 395 396 388 389 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 404 406 393 395 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 443 444 420 421 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 458 459 435 436 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 508 509 485 486 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 526 527 503 504 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 550 551 527 528 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 588 589 565 566 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 605 606 582 583 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 709 710 686 687 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 752 753 729 730 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 801 803 778 780 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 835 837 812 814 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref27">27</xref>
###xml 39 45 <span type="species:ncbi:9913">bovine</span>
Determination of sGC Activity-Purified bovine lung sGC (50 ng) was incubated at 37 degreesC for 10 min in a final volume of 100 mul with the indicated concentrations of donor compounds (GTN, NaNO2, and DEA/NO) in the absence and presence of purified ALDH1 or ALDH2 or BSA as indicated in the text and figure legends. Assay mixtures contained 50 mm triethanolamine HCl (pH 7.4), 5 mm MgCl2, 0.5 mm [alpha-32P]GTP (approximately250,000 cpm), 1 mm cGMP, and 2 mm DTT. Where indicated, chloral hydrate (1 or 10 mm), daidzin (0.1 mm), oxyhemoglobin (0.1 mm), flavin adenine dinucleotide (0.1 mm), or ODQ (0.1 mm) was additionally present. Reactions were terminated by the addition of 0.45 ml of zinc acetate (120 mm) and 0.45 ml of sodium bicarbonate (120 mm), followed by isolation and quantification of [32P]cGMP as described previously (27). Blank values were determined in the absence of sGC.
###end p 17
###begin p 18
###xml 0 73 0 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Determination of GTN-derived NO in the Presence of Purified ALDH Isoforms</italic>
###xml 241 243 241 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref28">28</xref>
###xml 253 254 253 254 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 335 336 335 336 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 354 355 354 355 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 365 366 365 366 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 528 529 528 529 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 542 543 542 543 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 593 594 593 594 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 776 777 763 764 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
Determination of GTN-derived NO in the Presence of Purified ALDH Isoforms-NO formation was measured with a Clark-type electrode (World Precision Instruments, Berlin, Germany), calibrated daily with acidified nitrite as described previously (28), in 50 mm triethanolamine HCl (pH 7.4) containing 1,000 units of superoxide dismutase, 2 mm DTT, and GTN (1 mm and 0.1 mm with ALDH1 and ALDH2, respectively). The incubation volume was 1 ml. Where indicated, measurements were performed in the presence of the nucleotide cofactors NAD+ or NADH (2 mm each) or the ALDH inhibitor chloral hydrate (10 mm). After equilibration at 37 degreesC, purified ALDH1 (0.5 mg) or ALDH2 (0.25 mg), which had been adjusted to 37 degreesC for 10 min, was added. The NO scavenger oxyhemoglobin (10 mum final concentration) was added in some experiments to confirm that the observed signals did indeed reflect formation of NO radical.
###end p 18
###begin p 19
###xml 0 29 0 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Analysis of ALDH-bound Metals</italic>
###xml 128 129 114 115 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 485 486 470 471 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
Analysis of ALDH-bound Metals-For the determination of metals in ALDH1 and ALDH2, protein solutions (100 mul, approximately80 mum) were mixed with nitric acid (1% (v/v) final concentration) and vigorously shaken for 10 min. The samples were screened for metals with an inductively coupled plasma mass spectrometer (Agilent 7500ce, Waldbronn, Germany) in the semiquantitative mode. Metal content of buffer was subtracted as blank. The concentrations of Fe, Cu, Mn, Mo, and Zn were <1 mum. Other metals were not detectable.
###end p 19
###begin title 20
RESULTS
###end title 20
###begin p 21
###xml 0 48 0 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Basic Characterization of Purified ALDH Isoforms</italic>
###xml 80 87 80 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli</italic>
###xml 294 301 294 301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="tbl1">Table 1</xref>
###xml 339 340 339 340 <sub xmlns:xlink="http://www.w3.org/1999/xlink">m</sub>
###xml 338 340 338 340 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K<sub>m</sub></italic>
###xml 465 467 465 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref25">25</xref>
###xml 80 87 <span type="species:ncbi:110766|species:ncbi:562">E. coli</span>
Basic Characterization of Purified ALDH Isoforms-The proteins obtained from the E. coli expression system were >95% pure as judged by polyacrylamide gel electrophoresis (data not shown). The enzyme kinetic parameters determined for the dehydrogenase and esterase activities of ALDH1 and ALDH2 (Table 1), including the significantly lower Km values for aldehyde and ester substrates and higher specific activity of ALDH2, agree well with values reported previously (25).
###end p 21
###begin p 22
###xml 0 7 0 7 <label xmlns:xlink="http://www.w3.org/1999/xlink">TABLE 1</label>
###xml 7 78 7 78 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Enzyme kinetic parameters of purified recombinant human ALDH1 and ALDH2</bold>
###xml 7 78 7 78 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="23"><bold>Enzyme kinetic parameters of purified recombinant human ALDH1 and ALDH2</bold></p>
###xml 213 214 213 214 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 78 395 78 393 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="24">Dehydrogenase and esterase activities were determined photometrically in the presence of increasing concentrations of acetaldehyde and <italic>p</italic>-nitrophenyl acetate, respectively, as described under &#8220;Experimental Procedures.&#8221; Data are mean values &#177; S.E. of the parameters determined for three different enzyme preparations.</p>
###xml 7 395 7 393 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="23"><bold>Enzyme kinetic parameters of purified recombinant human ALDH1 and ALDH2</bold></p><p textid="24">Dehydrogenase and esterase activities were determined photometrically in the presence of increasing concentrations of acetaldehyde and <italic>p</italic>-nitrophenyl acetate, respectively, as described under &#8220;Experimental Procedures.&#8221; Data are mean values &#177; S.E. of the parameters determined for three different enzyme preparations.</p></caption>
###xml 395 395 393 393 <th xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"/>
###xml 395 417 393 415 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Dehydrogenase activity</bold>
###xml 417 417 415 415 <hr xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 395 417 393 415 <th xmlns:xlink="http://www.w3.org/1999/xlink" colspan="2" rowspan="1" align="center" valign="bottom"><bold>Dehydrogenase activity</bold><hr/></th>
###xml 417 434 415 432 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Esterase activity</bold>
###xml 434 434 432 432 <hr xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 417 434 415 432 <th xmlns:xlink="http://www.w3.org/1999/xlink" colspan="2" rowspan="1" align="center" valign="bottom"><bold>Esterase activity</bold><hr/></th>
###xml 395 434 393 432 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th colspan="1" rowspan="1" align="center" valign="top"/><th colspan="2" rowspan="1" align="center" valign="bottom"><bold>Dehydrogenase activity</bold><hr/></th><th colspan="2" rowspan="1" align="center" valign="bottom"><bold>Esterase activity</bold><hr/></th></tr>
###xml 434 434 432 432 <th xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"/>
###xml 435 436 433 434 <sub xmlns:xlink="http://www.w3.org/1999/xlink">m</sub>
###xml 434 436 432 434 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K<sub>m</sub></italic>
###xml 434 436 432 434 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>K<sub>m</sub></italic></bold>
###xml 434 436 432 434 <th xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"><bold><italic>K<sub>m</sub></italic></bold></th>
###xml 436 437 434 435 <italic xmlns:xlink="http://www.w3.org/1999/xlink">V</italic>
###xml 437 440 435 438 <sub xmlns:xlink="http://www.w3.org/1999/xlink">max</sub>
###xml 436 440 434 438 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>V</italic><sub>max</sub></bold>
###xml 436 440 434 438 <th xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"><bold><italic>V</italic><sub>max</sub></bold></th>
###xml 441 442 439 440 <sub xmlns:xlink="http://www.w3.org/1999/xlink">m</sub>
###xml 440 442 438 440 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K<sub>m</sub></italic>
###xml 440 442 438 440 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>K<sub>m</sub></italic></bold>
###xml 440 442 438 440 <th xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"><bold><italic>K<sub>m</sub></italic></bold></th>
###xml 442 443 440 441 <italic xmlns:xlink="http://www.w3.org/1999/xlink">V</italic>
###xml 443 446 441 444 <sub xmlns:xlink="http://www.w3.org/1999/xlink">max</sub>
###xml 442 446 440 444 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>V</italic><sub>max</sub></bold>
###xml 442 446 440 444 <th xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"><bold><italic>V</italic><sub>max</sub></bold></th>
###xml 434 446 432 444 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th colspan="1" rowspan="1" align="center" valign="top"/><th colspan="1" rowspan="1" align="center" valign="top"><bold><italic>K<sub>m</sub></italic></bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold><italic>V</italic><sub>max</sub></bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold><italic>K<sub>m</sub></italic></bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold><italic>V</italic><sub>max</sub></bold></th></tr>
###xml 395 446 393 444 <thead xmlns:xlink="http://www.w3.org/1999/xlink"><tr><th colspan="1" rowspan="1" align="center" valign="top"/><th colspan="2" rowspan="1" align="center" valign="bottom"><bold>Dehydrogenase activity</bold><hr/></th><th colspan="2" rowspan="1" align="center" valign="bottom"><bold>Esterase activity</bold><hr/></th></tr><tr><th colspan="1" rowspan="1" align="center" valign="top"/><th colspan="1" rowspan="1" align="center" valign="top"><bold><italic>K<sub>m</sub></italic></bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold><italic>V</italic><sub>max</sub></bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold><italic>K<sub>m</sub></italic></bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold><italic>V</italic><sub>max</sub></bold></th></tr></thead>
###xml 446 446 444 444 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"/>
###xml 449 450 446 447 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 449 450 446 447 <italic xmlns:xlink="http://www.w3.org/1999/xlink"><sc>m</sc></italic>
###xml 446 450 444 447 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> &#956;<italic><sc>m</sc></italic></td>
###xml 460 462 457 459 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-1</sup>
###xml 467 469 464 466 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-1</sup>
###xml 450 469 447 466 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nmol &#215; min<sup>-1</sup> &#215; mg<sup>-1</sup></italic>
###xml 450 469 447 466 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"><italic>nmol &#215; min<sup>-1</sup> &#215; mg<sup>-1</sup></italic></td>
###xml 472 473 468 469 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 472 473 468 469 <italic xmlns:xlink="http://www.w3.org/1999/xlink"><sc>m</sc></italic>
###xml 469 473 466 469 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> &#956;<italic><sc>m</sc></italic></td>
###xml 483 485 479 481 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-1</sup>
###xml 490 492 486 488 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-1</sup>
###xml 473 492 469 488 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nmol &#215; min<sup>-1</sup> &#215; mg<sup>-1</sup></italic>
###xml 473 492 469 488 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"><italic>nmol &#215; min<sup>-1</sup> &#215; mg<sup>-1</sup></italic></td>
###xml 446 492 444 488 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"> &#956;<italic><sc>m</sc></italic></td><td colspan="1" rowspan="1" align="center" valign="top"><italic>nmol &#215; min<sup>-1</sup> &#215; mg<sup>-1</sup></italic></td><td colspan="1" rowspan="1" align="center" valign="top"> &#956;<italic><sc>m</sc></italic></td><td colspan="1" rowspan="1" align="center" valign="top"><italic>nmol &#215; min<sup>-1</sup> &#215; mg<sup>-1</sup></italic></td></tr>
###xml 492 497 488 493 <bold xmlns:xlink="http://www.w3.org/1999/xlink">ALDH1</bold>
###xml 492 497 488 493 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"><bold>ALDH1</bold></td>
###xml 497 509 493 503 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 200 &#177; 14 </td>
###xml 509 523 503 515 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 1,060 &#177; 20 </td>
###xml 523 538 515 528 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 0.69 &#177; 0.03 </td>
###xml 538 549 528 537 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 155 &#177; 4 </td>
###xml 492 549 488 537 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="center" valign="top"><bold>ALDH1</bold></td><td colspan="1" rowspan="1" align="center" valign="top"> 200 &#177; 14 </td><td colspan="1" rowspan="1" align="center" valign="top"> 1,060 &#177; 20 </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.69 &#177; 0.03 </td><td colspan="1" rowspan="1" align="center" valign="top"> 155 &#177; 4 </td></tr>
###xml 549 554 537 542 <bold xmlns:xlink="http://www.w3.org/1999/xlink">ALDH2</bold>
###xml 549 554 537 542 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"><bold>ALDH2</bold></td>
###xml 554 570 542 556 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 0.33 &#177; 0.005 </td>
###xml 570 584 556 568 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 4,000 &#177; 30 </td>
###xml 584 599 568 581 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 0.18 &#177; 0.01 </td>
###xml 599 610 581 590 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 210 &#177; 9 </td>
###xml 549 610 537 590 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="center" valign="top"><bold>ALDH2</bold></td><td colspan="1" rowspan="1" align="center" valign="top"> 0.33 &#177; 0.005 </td><td colspan="1" rowspan="1" align="center" valign="top"> 4,000 &#177; 30 </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.18 &#177; 0.01 </td><td colspan="1" rowspan="1" align="center" valign="top"> 210 &#177; 9 </td></tr>
###xml 446 610 444 590 <tbody xmlns:xlink="http://www.w3.org/1999/xlink"><tr><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"> &#956;<italic><sc>m</sc></italic></td><td colspan="1" rowspan="1" align="center" valign="top"><italic>nmol &#215; min<sup>-1</sup> &#215; mg<sup>-1</sup></italic></td><td colspan="1" rowspan="1" align="center" valign="top"> &#956;<italic><sc>m</sc></italic></td><td colspan="1" rowspan="1" align="center" valign="top"><italic>nmol &#215; min<sup>-1</sup> &#215; mg<sup>-1</sup></italic></td></tr><tr><td colspan="1" rowspan="1" align="center" valign="top"><bold>ALDH1</bold></td><td colspan="1" rowspan="1" align="center" valign="top"> 200 &#177; 14 </td><td colspan="1" rowspan="1" align="center" valign="top"> 1,060 &#177; 20 </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.69 &#177; 0.03 </td><td colspan="1" rowspan="1" align="center" valign="top"> 155 &#177; 4 </td></tr><tr><td colspan="1" rowspan="1" align="center" valign="top"><bold>ALDH2</bold></td><td colspan="1" rowspan="1" align="center" valign="top"> 0.33 &#177; 0.005 </td><td colspan="1" rowspan="1" align="center" valign="top"> 4,000 &#177; 30 </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.18 &#177; 0.01 </td><td colspan="1" rowspan="1" align="center" valign="top"> 210 &#177; 9 </td></tr></tbody>
###xml 395 610 393 590 <table xmlns:xlink="http://www.w3.org/1999/xlink" frame="hsides" rules="groups"><thead><tr><th colspan="1" rowspan="1" align="center" valign="top"/><th colspan="2" rowspan="1" align="center" valign="bottom"><bold>Dehydrogenase activity</bold><hr/></th><th colspan="2" rowspan="1" align="center" valign="bottom"><bold>Esterase activity</bold><hr/></th></tr><tr><th colspan="1" rowspan="1" align="center" valign="top"/><th colspan="1" rowspan="1" align="center" valign="top"><bold><italic>K<sub>m</sub></italic></bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold><italic>V</italic><sub>max</sub></bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold><italic>K<sub>m</sub></italic></bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold><italic>V</italic><sub>max</sub></bold></th></tr></thead><tbody><tr><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"> &#956;<italic><sc>m</sc></italic></td><td colspan="1" rowspan="1" align="center" valign="top"><italic>nmol &#215; min<sup>-1</sup> &#215; mg<sup>-1</sup></italic></td><td colspan="1" rowspan="1" align="center" valign="top"> &#956;<italic><sc>m</sc></italic></td><td colspan="1" rowspan="1" align="center" valign="top"><italic>nmol &#215; min<sup>-1</sup> &#215; mg<sup>-1</sup></italic></td></tr><tr><td colspan="1" rowspan="1" align="center" valign="top"><bold>ALDH1</bold></td><td colspan="1" rowspan="1" align="center" valign="top"> 200 &#177; 14 </td><td colspan="1" rowspan="1" align="center" valign="top"> 1,060 &#177; 20 </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.69 &#177; 0.03 </td><td colspan="1" rowspan="1" align="center" valign="top"> 155 &#177; 4 </td></tr><tr><td colspan="1" rowspan="1" align="center" valign="top"><bold>ALDH2</bold></td><td colspan="1" rowspan="1" align="center" valign="top"> 0.33 &#177; 0.005 </td><td colspan="1" rowspan="1" align="center" valign="top"> 4,000 &#177; 30 </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.18 &#177; 0.01 </td><td colspan="1" rowspan="1" align="center" valign="top"> 210 &#177; 9 </td></tr></tbody></table>
###xml 0 610 0 590 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="tbl1"><label>TABLE 1</label><caption><p textid="23"><bold>Enzyme kinetic parameters of purified recombinant human ALDH1 and ALDH2</bold></p><p textid="24">Dehydrogenase and esterase activities were determined photometrically in the presence of increasing concentrations of acetaldehyde and <italic>p</italic>-nitrophenyl acetate, respectively, as described under &#8220;Experimental Procedures.&#8221; Data are mean values &#177; S.E. of the parameters determined for three different enzyme preparations.</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="1" rowspan="1" align="center" valign="top"/><th colspan="2" rowspan="1" align="center" valign="bottom"><bold>Dehydrogenase activity</bold><hr/></th><th colspan="2" rowspan="1" align="center" valign="bottom"><bold>Esterase activity</bold><hr/></th></tr><tr><th colspan="1" rowspan="1" align="center" valign="top"/><th colspan="1" rowspan="1" align="center" valign="top"><bold><italic>K<sub>m</sub></italic></bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold><italic>V</italic><sub>max</sub></bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold><italic>K<sub>m</sub></italic></bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold><italic>V</italic><sub>max</sub></bold></th></tr></thead><tbody><tr><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"> &#956;<italic><sc>m</sc></italic></td><td colspan="1" rowspan="1" align="center" valign="top"><italic>nmol &#215; min<sup>-1</sup> &#215; mg<sup>-1</sup></italic></td><td colspan="1" rowspan="1" align="center" valign="top"> &#956;<italic><sc>m</sc></italic></td><td colspan="1" rowspan="1" align="center" valign="top"><italic>nmol &#215; min<sup>-1</sup> &#215; mg<sup>-1</sup></italic></td></tr><tr><td colspan="1" rowspan="1" align="center" valign="top"><bold>ALDH1</bold></td><td colspan="1" rowspan="1" align="center" valign="top"> 200 &#177; 14 </td><td colspan="1" rowspan="1" align="center" valign="top"> 1,060 &#177; 20 </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.69 &#177; 0.03 </td><td colspan="1" rowspan="1" align="center" valign="top"> 155 &#177; 4 </td></tr><tr><td colspan="1" rowspan="1" align="center" valign="top"><bold>ALDH2</bold></td><td colspan="1" rowspan="1" align="center" valign="top"> 0.33 &#177; 0.005 </td><td colspan="1" rowspan="1" align="center" valign="top"> 4,000 &#177; 30 </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.18 &#177; 0.01 </td><td colspan="1" rowspan="1" align="center" valign="top"> 210 &#177; 9 </td></tr></tbody></table></table-wrap>
###xml 57 62 <span type="species:ncbi:9606">human</span>
TABLE 1Enzyme kinetic parameters of purified recombinant human ALDH1 and ALDH2Dehydrogenase and esterase activities were determined photometrically in the presence of increasing concentrations of acetaldehyde and p-nitrophenyl acetate, respectively, as described under "Experimental Procedures." Data are mean values +/- S.E. of the parameters determined for three different enzyme preparations.Dehydrogenase activityEsterase activityKmVmaxKmVmax mumnmol x min-1 x mg-1 mumnmol x min-1 x mg-1ALDH1 200 +/- 14  1,060 +/- 20  0.69 +/- 0.03  155 +/- 4 ALDH2 0.33 +/- 0.005  4,000 +/- 30  0.18 +/- 0.01  210 +/- 9
###end p 22
###begin p 23
###xml 0 71 0 71 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Enzyme kinetic parameters of purified recombinant human ALDH1 and ALDH2</bold>
###xml 50 55 <span type="species:ncbi:9606">human</span>
Enzyme kinetic parameters of purified recombinant human ALDH1 and ALDH2
###end p 23
###begin p 24
###xml 135 136 135 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
Dehydrogenase and esterase activities were determined photometrically in the presence of increasing concentrations of acetaldehyde and p-nitrophenyl acetate, respectively, as described under "Experimental Procedures." Data are mean values +/- S.E. of the parameters determined for three different enzyme preparations.
###end p 24
###begin p 25
###xml 0 29 0 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ALDH-catalyzed GTN Metabolism</italic>
###xml 167 173 167 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1</xref>
###xml 189 190 189 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 183 190 183 190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1<italic>A</italic></xref>
###xml 206 207 205 206 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 289 291 284 286 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;1</sup>
###xml 296 298 291 293 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;1</sup>
###xml 374 375 369 370 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 368 375 363 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1<italic>B</italic></xref>
###xml 482 484 463 465 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;1</sup>
###xml 489 491 470 472 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;1</sup>
###xml 553 555 532 534 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;1</sup>
###xml 560 562 539 541 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;1</sup>
###xml 652 653 631 632 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref5">5</xref>
###xml 655 656 634 635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref9">9</xref>
###xml 858 864 837 843 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2</xref>
###xml 955 957 934 936 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;1</sup>
###xml 962 964 941 943 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;1</sup>
###xml 1071 1072 1050 1051 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 1065 1072 1044 1051 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2<italic>A</italic></xref>
###xml 1085 1086 1064 1065 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 1134 1135 1100 1101 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1188 1189 1154 1155 <sub xmlns:xlink="http://www.w3.org/1999/xlink">m</sub>
###xml 1187 1189 1153 1155 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K<sub>m</sub></italic>
###xml 1263 1270 1229 1236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="tbl1">Table 1</xref>
###xml 1297 1298 1263 1264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref5">5</xref>
###xml 1300 1301 1266 1267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref9">9</xref>
###xml 1464 1465 1430 1431 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1574 1575 1538 1539 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1694 1695 1658 1659 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
ALDH-catalyzed GTN Metabolism-Determination of 1,2- and 1,3-GDN formation by radio thin layer chromatography revealed that both ALDH isoforms catalyze GTN metabolism (Fig. 1). ALDH1 (Fig. 1A) converted 2 mum GTN into 1,2- and 1,3-GDN with rates of 3.0 +/- 0.16 and 0.66 +/- 0.03 nmol x min-1 x mg-1, respectively. In the presence of this low GTN concentration, ALDH2 (Fig. 1B) exhibited approximately3-fold higher activity with respect to 1,2-GDN formation (9.00 +/- 0.28 nmol x min-1 x mg-1). Formation of 1,3-GDN was very low (0.18 +/- 0.01 nmol x min-1 x mg-1), confirming the selective conversion of GTN into the 1,2-isomer under these conditions (5, 9). As expected, chloral hydrate inhibited GTN metabolism by both isoforms, whereas daidzin showed marked selectivity for ALDH2. As revealed by the GTN concentration dependence of the reactions shown in Fig. 2, the two isoforms exhibited similar maximal 1,2-GDN-forming activities of 30-40 nmol x min-1 x mg-1 but differed significantly in GTN affinity and product distribution. Formation of 1,2-GDN by ALDH1 (Fig. 2A) and ALDH2 (B) was half-maximal at approximately200 and 20 mum GTN, respectively, apparently reflecting the lower Km values of ALDH2 measured with dehydrogenase and esterase substrates (see Table 1). As reported previously (5, 9), specific 1,2-GDN formation by ALDH2 was lost at increasing GTN concentrations, although formation of the 1,3-isomer did not exceed 1,2-GDN formation even at 1 mm GTN. In contrast, the ALDH1-catalyzed reaction resulted in predominant formation of the 1,3-isomer at >/=1 mm GTN. In fact, the rate of 1,2-GDN formation was significantly decreased at the highest GTN concentration tested (2.8 mm). Formation of 1,3-GDN was not affected by substrate-competitive inhibitors, indicating that it does not involve binding of GTN to the catalytic sites of the enzymes.
###end p 25
###begin p 26
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 1.</label>
###xml 34 35 34 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 48 49 48 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 9 51 9 51 <bold xmlns:xlink="http://www.w3.org/1999/xlink">GTN metabolism by ALDH1 (<italic>A</italic>) and ALDH2 (<italic>B</italic>).</bold>
###xml 157 158 149 150 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 160 162 152 154 <sup xmlns:xlink="http://www.w3.org/1999/xlink">14</sup>
###xml 172 173 164 165 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 178 179 170 171 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 184 185 176 177 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 194 195 186 187 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 204 205 196 197 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 209 210 201 202 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 215 216 207 208 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 230 231 222 223 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 277 279 269 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CH</italic>
###xml 9 517 9 507 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="27"><bold>GTN metabolism by ALDH1 (<italic>A</italic>) and ALDH2 (<italic>B</italic>).</bold> Purified ALDH1 and ALDH2 (4 &#956;g of each) were incubated at 37 &#176;C for 10 min in the presence of 2 &#956;<sc>m</sc> [<sup>14</sup>C]GTN, 3 m<sc>m</sc> MgCl<sub>2</sub>, 2 m<sc>m</sc> GSH, 2 m<sc>m</sc> DTT, 1 m<sc>m</sc> NAD<sup>+</sup>, 1 m<sc>m</sc> EDTA, and 1 m<sc>m</sc> EGTA. The enzyme inhibitors chloral hydrate (<italic>CH</italic>) and daidzin were present as indicated. 1,2- and 1,3-GDN were extracted and quantified by radio thin layer chromatography as described under &#8220;Experimental Procedures.&#8221; Data represent mean values &#177; S.E. of three independent experiments.</p>
###xml 9 517 9 507 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="27"><bold>GTN metabolism by ALDH1 (<italic>A</italic>) and ALDH2 (<italic>B</italic>).</bold> Purified ALDH1 and ALDH2 (4 &#956;g of each) were incubated at 37 &#176;C for 10 min in the presence of 2 &#956;<sc>m</sc> [<sup>14</sup>C]GTN, 3 m<sc>m</sc> MgCl<sub>2</sub>, 2 m<sc>m</sc> GSH, 2 m<sc>m</sc> DTT, 1 m<sc>m</sc> NAD<sup>+</sup>, 1 m<sc>m</sc> EDTA, and 1 m<sc>m</sc> EGTA. The enzyme inhibitors chloral hydrate (<italic>CH</italic>) and daidzin were present as indicated. 1,2- and 1,3-GDN were extracted and quantified by radio thin layer chromatography as described under &#8220;Experimental Procedures.&#8221; Data represent mean values &#177; S.E. of three independent experiments.</p></caption>
###xml 517 517 507 507 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0290842180001"/>
###xml 0 517 0 507 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig1"><label>FIGURE 1.</label><caption><p textid="27"><bold>GTN metabolism by ALDH1 (<italic>A</italic>) and ALDH2 (<italic>B</italic>).</bold> Purified ALDH1 and ALDH2 (4 &#956;g of each) were incubated at 37 &#176;C for 10 min in the presence of 2 &#956;<sc>m</sc> [<sup>14</sup>C]GTN, 3 m<sc>m</sc> MgCl<sub>2</sub>, 2 m<sc>m</sc> GSH, 2 m<sc>m</sc> DTT, 1 m<sc>m</sc> NAD<sup>+</sup>, 1 m<sc>m</sc> EDTA, and 1 m<sc>m</sc> EGTA. The enzyme inhibitors chloral hydrate (<italic>CH</italic>) and daidzin were present as indicated. 1,2- and 1,3-GDN were extracted and quantified by radio thin layer chromatography as described under &#8220;Experimental Procedures.&#8221; Data represent mean values &#177; S.E. of three independent experiments.</p></caption><graphic xlink:href="zbc0290842180001"/></fig>
FIGURE 1.GTN metabolism by ALDH1 (A) and ALDH2 (B). Purified ALDH1 and ALDH2 (4 mug of each) were incubated at 37 degreesC for 10 min in the presence of 2 mum [14C]GTN, 3 mm MgCl2, 2 mm GSH, 2 mm DTT, 1 mm NAD+, 1 mm EDTA, and 1 mm EGTA. The enzyme inhibitors chloral hydrate (CH) and daidzin were present as indicated. 1,2- and 1,3-GDN were extracted and quantified by radio thin layer chromatography as described under "Experimental Procedures." Data represent mean values +/- S.E. of three independent experiments.
###end p 26
###begin p 27
###xml 25 26 25 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 39 40 39 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 0 42 0 42 <bold xmlns:xlink="http://www.w3.org/1999/xlink">GTN metabolism by ALDH1 (<italic>A</italic>) and ALDH2 (<italic>B</italic>).</bold>
###xml 148 149 140 141 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 151 153 143 145 <sup xmlns:xlink="http://www.w3.org/1999/xlink">14</sup>
###xml 163 164 155 156 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 169 170 161 162 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 175 176 167 168 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 185 186 177 178 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 195 196 187 188 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 200 201 192 193 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 206 207 198 199 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 221 222 213 214 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 268 270 260 262 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CH</italic>
GTN metabolism by ALDH1 (A) and ALDH2 (B). Purified ALDH1 and ALDH2 (4 mug of each) were incubated at 37 degreesC for 10 min in the presence of 2 mum [14C]GTN, 3 mm MgCl2, 2 mm GSH, 2 mm DTT, 1 mm NAD+, 1 mm EDTA, and 1 mm EGTA. The enzyme inhibitors chloral hydrate (CH) and daidzin were present as indicated. 1,2- and 1,3-GDN were extracted and quantified by radio thin layer chromatography as described under "Experimental Procedures." Data represent mean values +/- S.E. of three independent experiments.
###end p 27
###begin p 28
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 2.</label>
###xml 81 82 81 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 95 96 95 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 9 98 9 98 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Dependence on GTN concentration of 1,2- and 1,3-GDN formation by ALDH1 (<italic>A</italic>) and ALDH2 (<italic>B</italic>).</bold>
###xml 203 204 196 197 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 209 210 202 203 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 215 216 208 209 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 225 226 218 219 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 235 236 228 229 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 240 241 233 234 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 246 247 239 240 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 257 258 250 251 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 302 304 295 297 <sup xmlns:xlink="http://www.w3.org/1999/xlink">14</sup>
###xml 9 508 9 499 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="29"><bold>Dependence on GTN concentration of 1,2- and 1,3-GDN formation by ALDH1 (<italic>A</italic>) and ALDH2 (<italic>B</italic>).</bold> Purified ALDH1 and ALDH2 (4 &#956;g of each) were incubated at 37 &#176;C for 10 min in the presence of 3 m<sc>m</sc> MgCl<sub>2</sub>, 2 m<sc>m</sc> GSH, 2 m<sc>m</sc> DTT, 1 m<sc>m</sc> NAD<sup>+</sup>, 1 m<sc>m</sc> EDTA, 1 m<sc>m</sc> EGTA, and the indicated concentrations of [<sup>14</sup>C]GTN. 1,2- and 1,3-GDN were extracted and quantified by radio thin layer chromatography as described under &#8220;Experimental Procedures.&#8221; Data represent mean values &#177; S.E. of three independent experiments.</p>
###xml 9 508 9 499 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="29"><bold>Dependence on GTN concentration of 1,2- and 1,3-GDN formation by ALDH1 (<italic>A</italic>) and ALDH2 (<italic>B</italic>).</bold> Purified ALDH1 and ALDH2 (4 &#956;g of each) were incubated at 37 &#176;C for 10 min in the presence of 3 m<sc>m</sc> MgCl<sub>2</sub>, 2 m<sc>m</sc> GSH, 2 m<sc>m</sc> DTT, 1 m<sc>m</sc> NAD<sup>+</sup>, 1 m<sc>m</sc> EDTA, 1 m<sc>m</sc> EGTA, and the indicated concentrations of [<sup>14</sup>C]GTN. 1,2- and 1,3-GDN were extracted and quantified by radio thin layer chromatography as described under &#8220;Experimental Procedures.&#8221; Data represent mean values &#177; S.E. of three independent experiments.</p></caption>
###xml 508 508 499 499 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0290842180002"/>
###xml 0 508 0 499 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig2"><label>FIGURE 2.</label><caption><p textid="29"><bold>Dependence on GTN concentration of 1,2- and 1,3-GDN formation by ALDH1 (<italic>A</italic>) and ALDH2 (<italic>B</italic>).</bold> Purified ALDH1 and ALDH2 (4 &#956;g of each) were incubated at 37 &#176;C for 10 min in the presence of 3 m<sc>m</sc> MgCl<sub>2</sub>, 2 m<sc>m</sc> GSH, 2 m<sc>m</sc> DTT, 1 m<sc>m</sc> NAD<sup>+</sup>, 1 m<sc>m</sc> EDTA, 1 m<sc>m</sc> EGTA, and the indicated concentrations of [<sup>14</sup>C]GTN. 1,2- and 1,3-GDN were extracted and quantified by radio thin layer chromatography as described under &#8220;Experimental Procedures.&#8221; Data represent mean values &#177; S.E. of three independent experiments.</p></caption><graphic xlink:href="zbc0290842180002"/></fig>
FIGURE 2.Dependence on GTN concentration of 1,2- and 1,3-GDN formation by ALDH1 (A) and ALDH2 (B). Purified ALDH1 and ALDH2 (4 mug of each) were incubated at 37 degreesC for 10 min in the presence of 3 mm MgCl2, 2 mm GSH, 2 mm DTT, 1 mm NAD+, 1 mm EDTA, 1 mm EGTA, and the indicated concentrations of [14C]GTN. 1,2- and 1,3-GDN were extracted and quantified by radio thin layer chromatography as described under "Experimental Procedures." Data represent mean values +/- S.E. of three independent experiments.
###end p 28
###begin p 29
###xml 72 73 72 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 86 87 86 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 0 89 0 89 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Dependence on GTN concentration of 1,2- and 1,3-GDN formation by ALDH1 (<italic>A</italic>) and ALDH2 (<italic>B</italic>).</bold>
###xml 194 195 187 188 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 200 201 193 194 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 206 207 199 200 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 216 217 209 210 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 226 227 219 220 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 231 232 224 225 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 237 238 230 231 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 248 249 241 242 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 293 295 286 288 <sup xmlns:xlink="http://www.w3.org/1999/xlink">14</sup>
Dependence on GTN concentration of 1,2- and 1,3-GDN formation by ALDH1 (A) and ALDH2 (B). Purified ALDH1 and ALDH2 (4 mug of each) were incubated at 37 degreesC for 10 min in the presence of 3 mm MgCl2, 2 mm GSH, 2 mm DTT, 1 mm NAD+, 1 mm EDTA, 1 mm EGTA, and the indicated concentrations of [14C]GTN. 1,2- and 1,3-GDN were extracted and quantified by radio thin layer chromatography as described under "Experimental Procedures." Data represent mean values +/- S.E. of three independent experiments.
###end p 29
###begin p 30
###xml 0 61 0 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ALDH-catalyzed GTN Bioactivation Assayed as Activation of sGC</italic>
###xml 319 320 318 319 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 383 389 382 388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3</xref>
###xml 613 615 607 609 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;1</sup>
###xml 620 622 614 616 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;1</sup>
###xml 701 707 695 701 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5</xref>
ALDH-catalyzed GTN Bioactivation Assayed as Activation of sGC-Purified sGC was used for highly sensitive detection of NO-related bioactivity associated with ALDH-catalyzed GTN metabolism. Taking into account the different GTN affinities of the two ALDH isoforms, GTN was present at final concentrations of 100 and 10 mum in the assays with ALDH1 and ALDH2, respectively. As shown in Fig. 3, cGMP synthesis was not considerably increased over basal in the presence of increasing amounts of BSA that was used as a protein control (specific activity varied between 0.11 +/- 0.02 and 0.36 +/- 0.05 mumol of cGMP x min-1 x mg-1). In the absence of GTN, neither ALDH1 nor ALDH2 affected cGMP formation (see Fig. 5 below for GTN dependence). However, the combined presence of GTN and ALDH1 or ALDH2 led to significant sGC activation. The effects of the ALDH isoforms were dependent on the amount of added protein. Maximal rates of cGMP formation were observed with 50-100 mug of ALDH1 or 25 mug of ALDH2; sGC activity reached a plateau or even decreased at higher ALDH concentrations and never exceeded 30% of the rates measured with maximally NO-stimulated sGC.
###end p 30
###begin p 31
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 3.</label>
###xml 9 64 9 64 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Effects of ALDH1 and ALDH2 on activation of sGC by GTN.</bold>
###xml 152 154 142 144 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 166 167 156 157 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 199 200 177 178 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 205 206 183 184 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 211 212 189 190 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 226 227 204 205 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 320 321 297 298 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 347 348 323 324 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 359 361 335 337 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 9 505 9 479 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="32"><bold>Effects of ALDH1 and ALDH2 on activation of sGC by GTN.</bold> Purified sGC (50 ng) was incubated at 37 &#176;C for 10 min in the presence of [&#945;-<sup>32</sup>P]GTP (0.5 m<sc>m</sc>, &#8764;250,000 cpm), 5 m<sc>m</sc> MgCl<sub>2</sub>, 1 m<sc>m</sc> cGMP, and 2 m<sc>m</sc> DTT with the indicated amounts of purified ALDH1, ALDH2, or BSA. GTN concentration was 10 &#956;<sc>m</sc> (ALDH2 and BSA) or 100 &#956;<sc>m</sc> (ALDH1). [<sup>32</sup>P]cGMP was isolated and quantified as described under &#8220;Experimental Procedures.&#8221; Data are mean values &#177; S.E. of three independent experiments.</p>
###xml 9 505 9 479 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="32"><bold>Effects of ALDH1 and ALDH2 on activation of sGC by GTN.</bold> Purified sGC (50 ng) was incubated at 37 &#176;C for 10 min in the presence of [&#945;-<sup>32</sup>P]GTP (0.5 m<sc>m</sc>, &#8764;250,000 cpm), 5 m<sc>m</sc> MgCl<sub>2</sub>, 1 m<sc>m</sc> cGMP, and 2 m<sc>m</sc> DTT with the indicated amounts of purified ALDH1, ALDH2, or BSA. GTN concentration was 10 &#956;<sc>m</sc> (ALDH2 and BSA) or 100 &#956;<sc>m</sc> (ALDH1). [<sup>32</sup>P]cGMP was isolated and quantified as described under &#8220;Experimental Procedures.&#8221; Data are mean values &#177; S.E. of three independent experiments.</p></caption>
###xml 505 505 479 479 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0290842180003"/>
###xml 0 505 0 479 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig3"><label>FIGURE 3.</label><caption><p textid="32"><bold>Effects of ALDH1 and ALDH2 on activation of sGC by GTN.</bold> Purified sGC (50 ng) was incubated at 37 &#176;C for 10 min in the presence of [&#945;-<sup>32</sup>P]GTP (0.5 m<sc>m</sc>, &#8764;250,000 cpm), 5 m<sc>m</sc> MgCl<sub>2</sub>, 1 m<sc>m</sc> cGMP, and 2 m<sc>m</sc> DTT with the indicated amounts of purified ALDH1, ALDH2, or BSA. GTN concentration was 10 &#956;<sc>m</sc> (ALDH2 and BSA) or 100 &#956;<sc>m</sc> (ALDH1). [<sup>32</sup>P]cGMP was isolated and quantified as described under &#8220;Experimental Procedures.&#8221; Data are mean values &#177; S.E. of three independent experiments.</p></caption><graphic xlink:href="zbc0290842180003"/></fig>
FIGURE 3.Effects of ALDH1 and ALDH2 on activation of sGC by GTN. Purified sGC (50 ng) was incubated at 37 degreesC for 10 min in the presence of [alpha-32P]GTP (0.5 mm, approximately250,000 cpm), 5 mm MgCl2, 1 mm cGMP, and 2 mm DTT with the indicated amounts of purified ALDH1, ALDH2, or BSA. GTN concentration was 10 mum (ALDH2 and BSA) or 100 mum (ALDH1). [32P]cGMP was isolated and quantified as described under "Experimental Procedures." Data are mean values +/- S.E. of three independent experiments.
###end p 31
###begin p 32
###xml 0 55 0 55 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Effects of ALDH1 and ALDH2 on activation of sGC by GTN.</bold>
###xml 143 145 133 135 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 157 158 147 148 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 190 191 168 169 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 196 197 174 175 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 202 203 180 181 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 217 218 195 196 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 311 312 288 289 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 338 339 314 315 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 350 352 326 328 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
Effects of ALDH1 and ALDH2 on activation of sGC by GTN. Purified sGC (50 ng) was incubated at 37 degreesC for 10 min in the presence of [alpha-32P]GTP (0.5 mm, approximately250,000 cpm), 5 mm MgCl2, 1 mm cGMP, and 2 mm DTT with the indicated amounts of purified ALDH1, ALDH2, or BSA. GTN concentration was 10 mum (ALDH2 and BSA) or 100 mum (ALDH1). [32P]cGMP was isolated and quantified as described under "Experimental Procedures." Data are mean values +/- S.E. of three independent experiments.
###end p 32
###begin p 33
###xml 185 186 185 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 179 186 179 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4<italic>A</italic></xref>
###xml 413 414 400 401 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 479 480 466 467 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 843 845 830 832 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref29">29</xref>
###xml 847 849 834 836 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref30">30</xref>
###xml 916 918 903 905 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref31">31</xref>
###xml 920 922 907 909 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref32">32</xref>
###xml 991 992 978 979 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 985 992 972 979 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4<italic>B</italic></xref>
To see whether ALDH-catalyzed GTN bioactivation involves the catalytic site of the proteins, we tested the effects of the established ALDH inhibitors chloral hydrate and daidzin (Fig. 4A). To account for slight inhibition of NO stimulation of sGC (approximately10%), the effects of the added compounds are shown as the percent of maximal sGC activity determined under identical conditions in the presence of 10 mum DEA/NO. Although the non-selective compound chloral hydrate (1 mm) inhibited GTN-induced sGC activation mediated by both ALDH1 and ALDH2, daidzin selectively blocked the effect of ALDH2, strongly suggesting that binding of GTN to the substrate sites of the ALDH isoforms is essential for bioactivation. The potential involvement of NO binding to the regulatory heme group of sGC was tested with the heme site sGC inhibitor ODQ (29, 30), the superoxide-generating compound flavin adenine dinucleotide (31, 32), and the established NO scavenger oxyhemoglobin. As shown in Fig. 4B, all three agents completely inhibited ALDH-mediated sGC activation by GTN.
###end p 33
###begin p 34
###xml 0 6 0 6 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5</xref>
###xml 149 151 149 151 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50</sub>
###xml 175 176 172 173 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 203 204 197 198 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 356 362 338 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2</xref>
###xml 453 454 434 435 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 555 556 536 537 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
Fig. 5 shows the GTN concentration dependence of cGMP formation in the presence of ALDH1 and ALDH2. The effects of GTN were biphasic with apparent EC50 values of 42 +/- 2.9 mum (ALDH1) and 3.1 +/- 0.4 mum (ALDH2). The approximately10-fold higher potency of GTN to stimulate sGC in the presence of ALDH2 agrees well with the metabolism experiments shown in Fig. 2, suggesting a higher affinity of the nitrate for the mitochondrial isoform. GTN (10-300 mum) had no effect in the presence of BSA, which served as a protein control. Activation of sGC by 0.1 mm GTN was not affected by the trace metal chelator diethylenetriaminepentaacetic acid (data not shown).
###end p 34
###begin p 35
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 4.</label>
###xml 9 95 9 95 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Effects of enzyme inhibitors and NO scavengers on ALDH-mediated sGC activation by GTN.</bold>
###xml 195 196 192 193 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 213 214 209 210 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 257 263 253 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3</xref>
###xml 302 304 298 300 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CH</italic>
###xml 318 319 314 315 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 409 412 405 408 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FAD</italic>
###xml 451 456 447 452 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OxyHb</italic>
###xml 458 459 454 455 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 489 491 485 487 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 644 645 639 640 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 654 655 649 650 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 683 684 678 679 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 9 754 9 747 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="36"><bold>Effects of enzyme inhibitors and NO scavengers on ALDH-mediated sGC activation by GTN.</bold> Purified sGC was incubated with purified ALDH1 (50 &#956;g) or ALDH2 (25 &#956;g) in the presence of 100 &#956;<sc>m</sc> (ALDH1) or 10 &#956;<sc>m</sc> (ALDH2) GTN as described in the legend to <xref rid="fig3" ref-type="fig">Fig. 3</xref>. The ALDH inhibitors chloral hydrate (<italic>CH</italic>) or daidzin (<italic>A</italic>), the sGC inhibitor ODQ, the superoxide-generating compound flavin adenine dinucleotide (<italic>FAD</italic>), and the NO scavenger oxyhemoglobin (<italic>OxyHb</italic>)(<italic>B</italic>) were present as indicated. [<sup>32</sup>P]cGMP was isolated and quantified as described under &#8220;Experimental Procedures.&#8221; Data are expressed as percent of maximal sGC activity obtained with 10&#956;<sc>m</sc> DEA/NO (<italic>A</italic>) or specific sGC activity (<italic>B</italic>) and represent mean values &#177; S.E. of three independent experiments.</p>
###xml 9 754 9 747 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="36"><bold>Effects of enzyme inhibitors and NO scavengers on ALDH-mediated sGC activation by GTN.</bold> Purified sGC was incubated with purified ALDH1 (50 &#956;g) or ALDH2 (25 &#956;g) in the presence of 100 &#956;<sc>m</sc> (ALDH1) or 10 &#956;<sc>m</sc> (ALDH2) GTN as described in the legend to <xref rid="fig3" ref-type="fig">Fig. 3</xref>. The ALDH inhibitors chloral hydrate (<italic>CH</italic>) or daidzin (<italic>A</italic>), the sGC inhibitor ODQ, the superoxide-generating compound flavin adenine dinucleotide (<italic>FAD</italic>), and the NO scavenger oxyhemoglobin (<italic>OxyHb</italic>)(<italic>B</italic>) were present as indicated. [<sup>32</sup>P]cGMP was isolated and quantified as described under &#8220;Experimental Procedures.&#8221; Data are expressed as percent of maximal sGC activity obtained with 10&#956;<sc>m</sc> DEA/NO (<italic>A</italic>) or specific sGC activity (<italic>B</italic>) and represent mean values &#177; S.E. of three independent experiments.</p></caption>
###xml 754 754 747 747 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0290842180004"/>
###xml 0 754 0 747 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig4"><label>FIGURE 4.</label><caption><p textid="36"><bold>Effects of enzyme inhibitors and NO scavengers on ALDH-mediated sGC activation by GTN.</bold> Purified sGC was incubated with purified ALDH1 (50 &#956;g) or ALDH2 (25 &#956;g) in the presence of 100 &#956;<sc>m</sc> (ALDH1) or 10 &#956;<sc>m</sc> (ALDH2) GTN as described in the legend to <xref rid="fig3" ref-type="fig">Fig. 3</xref>. The ALDH inhibitors chloral hydrate (<italic>CH</italic>) or daidzin (<italic>A</italic>), the sGC inhibitor ODQ, the superoxide-generating compound flavin adenine dinucleotide (<italic>FAD</italic>), and the NO scavenger oxyhemoglobin (<italic>OxyHb</italic>)(<italic>B</italic>) were present as indicated. [<sup>32</sup>P]cGMP was isolated and quantified as described under &#8220;Experimental Procedures.&#8221; Data are expressed as percent of maximal sGC activity obtained with 10&#956;<sc>m</sc> DEA/NO (<italic>A</italic>) or specific sGC activity (<italic>B</italic>) and represent mean values &#177; S.E. of three independent experiments.</p></caption><graphic xlink:href="zbc0290842180004"/></fig>
FIGURE 4.Effects of enzyme inhibitors and NO scavengers on ALDH-mediated sGC activation by GTN. Purified sGC was incubated with purified ALDH1 (50 mug) or ALDH2 (25 mug) in the presence of 100 mum (ALDH1) or 10 mum (ALDH2) GTN as described in the legend to Fig. 3. The ALDH inhibitors chloral hydrate (CH) or daidzin (A), the sGC inhibitor ODQ, the superoxide-generating compound flavin adenine dinucleotide (FAD), and the NO scavenger oxyhemoglobin (OxyHb)(B) were present as indicated. [32P]cGMP was isolated and quantified as described under "Experimental Procedures." Data are expressed as percent of maximal sGC activity obtained with 10mum DEA/NO (A) or specific sGC activity (B) and represent mean values +/- S.E. of three independent experiments.
###end p 35
###begin p 36
###xml 0 86 0 86 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Effects of enzyme inhibitors and NO scavengers on ALDH-mediated sGC activation by GTN.</bold>
###xml 186 187 183 184 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 204 205 200 201 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 248 254 244 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3</xref>
###xml 293 295 289 291 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CH</italic>
###xml 309 310 305 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 400 403 396 399 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FAD</italic>
###xml 442 447 438 443 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OxyHb</italic>
###xml 449 450 445 446 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 480 482 476 478 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 635 636 630 631 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 645 646 640 641 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 674 675 669 670 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
Effects of enzyme inhibitors and NO scavengers on ALDH-mediated sGC activation by GTN. Purified sGC was incubated with purified ALDH1 (50 mug) or ALDH2 (25 mug) in the presence of 100 mum (ALDH1) or 10 mum (ALDH2) GTN as described in the legend to Fig. 3. The ALDH inhibitors chloral hydrate (CH) or daidzin (A), the sGC inhibitor ODQ, the superoxide-generating compound flavin adenine dinucleotide (FAD), and the NO scavenger oxyhemoglobin (OxyHb)(B) were present as indicated. [32P]cGMP was isolated and quantified as described under "Experimental Procedures." Data are expressed as percent of maximal sGC activity obtained with 10mum DEA/NO (A) or specific sGC activity (B) and represent mean values +/- S.E. of three independent experiments.
###end p 36
###begin p 37
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 5.</label>
###xml 9 69 9 69 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Effect of GTN concentration on ALDH-mediated sGC activation.</bold>
###xml 181 187 178 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3</xref>
###xml 245 247 242 244 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 9 391 9 386 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="38"><bold>Effect of GTN concentration on ALDH-mediated sGC activation.</bold> Purified sGC was incubated with ALDH1 (50 &#956;g) or ALDH2 (25 &#956;g) or BSA (50 &#956;g) as described in the legend to <xref rid="fig3" ref-type="fig">Fig. 3</xref> in the presence of the indicated concentrations of GTN. [<sup>32</sup>P]cGMP was isolated and quantified as described under &#8220;Experimental Procedures.&#8221; Data are mean values &#177; S.E. of three independent experiments.</p>
###xml 9 391 9 386 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="38"><bold>Effect of GTN concentration on ALDH-mediated sGC activation.</bold> Purified sGC was incubated with ALDH1 (50 &#956;g) or ALDH2 (25 &#956;g) or BSA (50 &#956;g) as described in the legend to <xref rid="fig3" ref-type="fig">Fig. 3</xref> in the presence of the indicated concentrations of GTN. [<sup>32</sup>P]cGMP was isolated and quantified as described under &#8220;Experimental Procedures.&#8221; Data are mean values &#177; S.E. of three independent experiments.</p></caption>
###xml 391 391 386 386 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0290842180005"/>
###xml 0 391 0 386 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig5"><label>FIGURE 5.</label><caption><p textid="38"><bold>Effect of GTN concentration on ALDH-mediated sGC activation.</bold> Purified sGC was incubated with ALDH1 (50 &#956;g) or ALDH2 (25 &#956;g) or BSA (50 &#956;g) as described in the legend to <xref rid="fig3" ref-type="fig">Fig. 3</xref> in the presence of the indicated concentrations of GTN. [<sup>32</sup>P]cGMP was isolated and quantified as described under &#8220;Experimental Procedures.&#8221; Data are mean values &#177; S.E. of three independent experiments.</p></caption><graphic xlink:href="zbc0290842180005"/></fig>
FIGURE 5.Effect of GTN concentration on ALDH-mediated sGC activation. Purified sGC was incubated with ALDH1 (50 mug) or ALDH2 (25 mug) or BSA (50 mug) as described in the legend to Fig. 3 in the presence of the indicated concentrations of GTN. [32P]cGMP was isolated and quantified as described under "Experimental Procedures." Data are mean values +/- S.E. of three independent experiments.
###end p 37
###begin p 38
###xml 0 60 0 60 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Effect of GTN concentration on ALDH-mediated sGC activation.</bold>
###xml 172 178 169 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3</xref>
###xml 236 238 233 235 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
Effect of GTN concentration on ALDH-mediated sGC activation. Purified sGC was incubated with ALDH1 (50 mug) or ALDH2 (25 mug) or BSA (50 mug) as described in the legend to Fig. 3 in the presence of the indicated concentrations of GTN. [32P]cGMP was isolated and quantified as described under "Experimental Procedures." Data are mean values +/- S.E. of three independent experiments.
###end p 38
###begin p 39
###xml 0 61 0 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ALDH-catalyzed GTN Bioactivation Resulting in Formation of NO</italic>
###xml 191 192 191 192 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 793 799 793 799 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6</xref>
###xml 820 821 820 821 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 833 834 833 834 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 978 979 973 974 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 985 987 980 982 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;1</sup>
###xml 992 994 987 989 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;1</sup>
###xml 1110 1111 1100 1101 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1203 1204 1193 1194 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1372 1373 1362 1363 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1506 1507 1491 1492 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1513 1515 1498 1500 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;1</sup>
###xml 1520 1522 1505 1507 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;1</sup>
###xml 1599 1600 1581 1582 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1628 1629 1607 1608 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1913 1914 1892 1893 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 2005 2006 1984 1985 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 1999 2006 1978 1985 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6<italic>C</italic></xref>
ALDH-catalyzed GTN Bioactivation Resulting in Formation of NO-Inhibition of ALDH-mediated sGC activation by oxyhemoglobin and superoxide (generated via flavin adenine dinucleotide-triggered O2 reduction) suggested the involvement of free NO radical in GTN bioactivity. Therefore, we attempted to measure GTN-derived NO with a Clark-type electrode. In preliminary experiments, we observed relatively small, transient NO signals that were markedly enhanced and prolonged in the presence of superoxide dismutase (data not shown). To effectively prevent this apparent superoxide-mediated NO decay, all NO assays were performed in the presence of 1,000 units/ml of superoxide dismutase. Other experimental conditions were chosen to maximize GTN bioactivation according to the sGC data. As shown in Fig. 6, addition of ALDH1 (A) or ALDH2 (B) to GTN-containing assay mixtures resulted in the appearance of pronounced NO signals with initial rates of 1.68 +/- 0.06 and 1.76 +/- 0.012 mum x min-1 x mg-1, respectively. The maximal NO concentrations measured with ALDH1 and ALDH2 were 0.47 +/- 0.01 and 0.33 +/- 0.001 mum, respectively. No detectable signals were observed in the presence of chloral hydrate (10 mm). Chloral hydrate did not affect NO signals derived from DEA/NO decomposition (data not shown). The apparent NO formation mediated by both isoforms was enhanced by NAD+, which stimulates GTN metabolism. The nucleotide increased both initial rates of NO formation (to 8.40 +/- 0.08 and 4.08 +/- 0.08 mum x min-1 x mg-1 ALDH1 and ALDH2, respectively) and NO peak concentrations (0.90 +/- 0.007 mum ALDH1 and 0.57 +/- 0.003 mum ALDH2). We reasoned that NO formation may involve nitrite reduction (see below) and therefore tested NADH as a potential reducing cofactor. NADH enhanced NO formation in terms of initial rates and peak concentrations, but the effects were less pronounced than those observed with NAD+. Signals elicited by ALDH1 or ALDH2 decayed rapidly upon addition of oxyhemoglobin (Fig. 6C), indicating that the signals reflected formation of free NO radical.
###end p 39
###begin p 40
###xml 0 48 0 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ALDH-mediated Bioactivation of Inorganic Nitrite</italic>
###xml 97 98 97 98 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref5">5</xref>
###xml 448 454 448 454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7</xref>
###xml 519 521 516 518 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;1</sup>
###xml 526 528 523 525 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;1</sup>
###xml 552 553 549 550 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 698 699 683 684 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
ALDH-mediated Bioactivation of Inorganic Nitrite-Because ALDH2 reduces GTN to inorganic nitrite (5), we speculated that the observed NO formation could be due to intrinsic nitrite reductase activity of the ALDH isoforms. To test this hypothesis, we used nitrite instead of GTN in sGC assays as potential ALDH substrate. To minimize thiol-mediated non-enzymatic bioactivation of nitrite, the assays were performed in the absence of DTT. As shown in Fig. 7, sGC exhibited a specific activity of 0.87 +/- 0.014 mumol x min-1 x mg-1 in the presence of 10 mm nitrite. This activity was increased approximately2- or 4-fold in the additional presence of ALDH1 or ALDH2, respectively. Chloral hydrate (10 mm) had no effect on sGC activity in the presence of nitrite alone but completely inhibited the effects of ALDH1 and ALDH2, excluding nonspecific protein effects.
###end p 40
###begin title 41
DISCUSSION
###end title 41
###begin p 42
###xml 325 326 325 326 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 502 503 502 503 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref5">5</xref>
###xml 505 506 505 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref9">9</xref>
###xml 574 575 574 575 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 599 601 599 601 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;1</sup>
###xml 606 608 606 608 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8211;1</sup>
###xml 723 725 711 713 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cf</italic>
###xml 727 733 715 721 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2</xref>
###xml 1118 1119 1106 1107 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
The present study demonstrates that GTN metabolism catalyzed by purified ALDH isoforms is associated with formation of free NO radical, resulting in pronounced sGC activation. Considering that enzymatic nitrite reduction by the respiratory chain does not appear to contribute significantly to mitochondrial GTN bioactivation,3 these results may provide a simple and conclusive explanation for previous reports showing that ALDH2-catalyzed GTN metabolism triggers accumulation of cGMP in blood vessels (5, 9). The initial rates of NO formation measured in the presence of NAD+ (8.4 and 4.0 nmol x min-1 x mg-1) suggest that NO formation accounts for approximately10% of total GTN turnover under our experimental conditions (cf. Fig. 2). However, the transient time course of the NO signals that we observed even in the presence of 1,000 units/ml of superoxide dismutase indicates that the true rates might have been underestimated because of additional, unknown NO consumption pathways. This is even more relevant for the degree of sGC activation, which had to be measured in the absence of superoxide dismutase and NAD+ to avoid interference of these agents with the enzyme assay. Thus, specific NO-forming activity and, in particular, sGC activation measured under our experimental conditions most likely reflect the lower limit of the true efficiency of ALDH-catalyzed GTN bioactivation.
###end p 42
###begin p 43
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 6.</label>
###xml 9 70 9 70 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Formation of GTN-derived NO in the presence of ALDH isoforms.</bold>
###xml 95 96 95 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 117 118 117 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 162 163 156 157 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 173 174 167 168 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 224 225 218 219 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 239 240 233 234 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 267 269 261 263 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CH</italic>
###xml 275 276 269 270 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 378 379 372 373 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 453 459 447 453 <italic xmlns:xlink="http://www.w3.org/1999/xlink">arrows</italic>
###xml 498 499 491 492 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 585 586 578 579 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 591 592 584 585 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 9 756 9 749 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="44"><bold>Formation of GTN-derived NO in the presence of ALDH isoforms.</bold> Purified ALDH1 (0.5 mg; <italic>A</italic>) or ALDH2 (0.25 mg; <italic>B</italic>) was incubated at 37 &#176;C with GTN (1 m<sc>m</sc> and 0.1 m<sc>m</sc>, respectively) in the absence and presence of NAD<sup>+</sup> and NADH (2 m<sc>m</sc> each) or chloral hydrate (<italic>CH</italic>; 10 m<sc>m</sc>). NO formation was monitored with a specific electrode as described under &#8220;Experimental Procedures.&#8221; <italic>C</italic> shows the effect of oxyhemoglobin, added at the time points indicated by <italic>arrows</italic> to give a final concentration of 10 &#956;<sc>m</sc>, on the NO signals obtained from ALDH1 and ALDH2 incubated with GTN as described for <italic>A</italic> and <italic>B</italic> in the absence of nucleotides. The effect on NO derived from DEA/NO is shown as the control. The traces shown are representative for three independent experiments.</p>
###xml 9 756 9 749 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="44"><bold>Formation of GTN-derived NO in the presence of ALDH isoforms.</bold> Purified ALDH1 (0.5 mg; <italic>A</italic>) or ALDH2 (0.25 mg; <italic>B</italic>) was incubated at 37 &#176;C with GTN (1 m<sc>m</sc> and 0.1 m<sc>m</sc>, respectively) in the absence and presence of NAD<sup>+</sup> and NADH (2 m<sc>m</sc> each) or chloral hydrate (<italic>CH</italic>; 10 m<sc>m</sc>). NO formation was monitored with a specific electrode as described under &#8220;Experimental Procedures.&#8221; <italic>C</italic> shows the effect of oxyhemoglobin, added at the time points indicated by <italic>arrows</italic> to give a final concentration of 10 &#956;<sc>m</sc>, on the NO signals obtained from ALDH1 and ALDH2 incubated with GTN as described for <italic>A</italic> and <italic>B</italic> in the absence of nucleotides. The effect on NO derived from DEA/NO is shown as the control. The traces shown are representative for three independent experiments.</p></caption>
###xml 756 756 749 749 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0290842180006"/>
###xml 0 756 0 749 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig6"><label>FIGURE 6.</label><caption><p textid="44"><bold>Formation of GTN-derived NO in the presence of ALDH isoforms.</bold> Purified ALDH1 (0.5 mg; <italic>A</italic>) or ALDH2 (0.25 mg; <italic>B</italic>) was incubated at 37 &#176;C with GTN (1 m<sc>m</sc> and 0.1 m<sc>m</sc>, respectively) in the absence and presence of NAD<sup>+</sup> and NADH (2 m<sc>m</sc> each) or chloral hydrate (<italic>CH</italic>; 10 m<sc>m</sc>). NO formation was monitored with a specific electrode as described under &#8220;Experimental Procedures.&#8221; <italic>C</italic> shows the effect of oxyhemoglobin, added at the time points indicated by <italic>arrows</italic> to give a final concentration of 10 &#956;<sc>m</sc>, on the NO signals obtained from ALDH1 and ALDH2 incubated with GTN as described for <italic>A</italic> and <italic>B</italic> in the absence of nucleotides. The effect on NO derived from DEA/NO is shown as the control. The traces shown are representative for three independent experiments.</p></caption><graphic xlink:href="zbc0290842180006"/></fig>
FIGURE 6.Formation of GTN-derived NO in the presence of ALDH isoforms. Purified ALDH1 (0.5 mg; A) or ALDH2 (0.25 mg; B) was incubated at 37 degreesC with GTN (1 mm and 0.1 mm, respectively) in the absence and presence of NAD+ and NADH (2 mm each) or chloral hydrate (CH; 10 mm). NO formation was monitored with a specific electrode as described under "Experimental Procedures." C shows the effect of oxyhemoglobin, added at the time points indicated by arrows to give a final concentration of 10 mum, on the NO signals obtained from ALDH1 and ALDH2 incubated with GTN as described for A and B in the absence of nucleotides. The effect on NO derived from DEA/NO is shown as the control. The traces shown are representative for three independent experiments.
###end p 43
###begin p 44
###xml 0 61 0 61 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Formation of GTN-derived NO in the presence of ALDH isoforms.</bold>
###xml 86 87 86 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 108 109 108 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 153 154 147 148 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 164 165 158 159 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 215 216 209 210 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 230 231 224 225 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 258 260 252 254 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CH</italic>
###xml 266 267 260 261 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 369 370 363 364 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 444 450 438 444 <italic xmlns:xlink="http://www.w3.org/1999/xlink">arrows</italic>
###xml 489 490 482 483 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 576 577 569 570 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 582 583 575 576 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
Formation of GTN-derived NO in the presence of ALDH isoforms. Purified ALDH1 (0.5 mg; A) or ALDH2 (0.25 mg; B) was incubated at 37 degreesC with GTN (1 mm and 0.1 mm, respectively) in the absence and presence of NAD+ and NADH (2 mm each) or chloral hydrate (CH; 10 mm). NO formation was monitored with a specific electrode as described under "Experimental Procedures." C shows the effect of oxyhemoglobin, added at the time points indicated by arrows to give a final concentration of 10 mum, on the NO signals obtained from ALDH1 and ALDH2 incubated with GTN as described for A and B in the absence of nucleotides. The effect on NO derived from DEA/NO is shown as the control. The traces shown are representative for three independent experiments.
###end p 44
###begin p 45
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 7.</label>
###xml 9 92 9 92 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Activation of sGC by inorganic nitrite in the presence of purified ALDH1 and ALDH2.</bold>
###xml 166 168 156 158 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 180 181 170 171 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 213 214 191 192 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 219 220 197 198 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 225 226 203 204 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 241 242 219 220 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 247 248 225 226 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 346 348 323 325 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CH</italic>
###xml 394 395 371 372 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 9 460 9 435 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="46"><bold>Activation of sGC by inorganic nitrite in the presence of purified ALDH1 and ALDH2.</bold> Purified sGC (50 ng) was incubated at 37 &#176;C for 10 min with [&#945;-<sup>32</sup>P]GTP (0.5 m<sc>m</sc>, &#8764;250,000 cpm), 5 m<sc>m</sc> MgCl<sub>2</sub>, 1 m<sc>m</sc> cGMP, and 10 m<sc>m</sc> NaNO<sub>2</sub> in the absence (control) or presence of purified ALDH1 and ALDH2 (50 &#956;g each). Chloral hydrate (<italic>CH</italic>) was present at a final concentration of 10 m<sc>m</sc>. Data are mean values &#177; S.E. of three independent experiments.</p>
###xml 9 460 9 435 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="46"><bold>Activation of sGC by inorganic nitrite in the presence of purified ALDH1 and ALDH2.</bold> Purified sGC (50 ng) was incubated at 37 &#176;C for 10 min with [&#945;-<sup>32</sup>P]GTP (0.5 m<sc>m</sc>, &#8764;250,000 cpm), 5 m<sc>m</sc> MgCl<sub>2</sub>, 1 m<sc>m</sc> cGMP, and 10 m<sc>m</sc> NaNO<sub>2</sub> in the absence (control) or presence of purified ALDH1 and ALDH2 (50 &#956;g each). Chloral hydrate (<italic>CH</italic>) was present at a final concentration of 10 m<sc>m</sc>. Data are mean values &#177; S.E. of three independent experiments.</p></caption>
###xml 460 460 435 435 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0290842180007"/>
###xml 0 460 0 435 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig7"><label>FIGURE 7.</label><caption><p textid="46"><bold>Activation of sGC by inorganic nitrite in the presence of purified ALDH1 and ALDH2.</bold> Purified sGC (50 ng) was incubated at 37 &#176;C for 10 min with [&#945;-<sup>32</sup>P]GTP (0.5 m<sc>m</sc>, &#8764;250,000 cpm), 5 m<sc>m</sc> MgCl<sub>2</sub>, 1 m<sc>m</sc> cGMP, and 10 m<sc>m</sc> NaNO<sub>2</sub> in the absence (control) or presence of purified ALDH1 and ALDH2 (50 &#956;g each). Chloral hydrate (<italic>CH</italic>) was present at a final concentration of 10 m<sc>m</sc>. Data are mean values &#177; S.E. of three independent experiments.</p></caption><graphic xlink:href="zbc0290842180007"/></fig>
FIGURE 7.Activation of sGC by inorganic nitrite in the presence of purified ALDH1 and ALDH2. Purified sGC (50 ng) was incubated at 37 degreesC for 10 min with [alpha-32P]GTP (0.5 mm, approximately250,000 cpm), 5 mm MgCl2, 1 mm cGMP, and 10 mm NaNO2 in the absence (control) or presence of purified ALDH1 and ALDH2 (50 mug each). Chloral hydrate (CH) was present at a final concentration of 10 mm. Data are mean values +/- S.E. of three independent experiments.
###end p 45
###begin p 46
###xml 0 83 0 83 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Activation of sGC by inorganic nitrite in the presence of purified ALDH1 and ALDH2.</bold>
###xml 157 159 147 149 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 171 172 161 162 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 204 205 182 183 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 210 211 188 189 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 216 217 194 195 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 232 233 210 211 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 238 239 216 217 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 337 339 314 316 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CH</italic>
###xml 385 386 362 363 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
Activation of sGC by inorganic nitrite in the presence of purified ALDH1 and ALDH2. Purified sGC (50 ng) was incubated at 37 degreesC for 10 min with [alpha-32P]GTP (0.5 mm, approximately250,000 cpm), 5 mm MgCl2, 1 mm cGMP, and 10 mm NaNO2 in the absence (control) or presence of purified ALDH1 and ALDH2 (50 mug each). Chloral hydrate (CH) was present at a final concentration of 10 mm. Data are mean values +/- S.E. of three independent experiments.
###end p 46
###begin p 47
###xml 322 324 322 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref33">33</xref>
###xml 325 327 325 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref35">35</xref>
###xml 538 539 538 539 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fn" rid="fn4">4</xref>
###xml 637 639 637 639 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref36">36</xref>
###xml 852 858 852 858 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5</xref>
###xml 906 907 906 907 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref3">3</xref>
###xml 1182 1188 1182 1188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3</xref>
The pronounced effect of superoxide dismutase on detectable GTN-derived free NO (data not shown) suggests significant generation of superoxide in our assays. An unavoidable superoxide source may be GTN itself, which was shown to trigger superoxide formation in blood vessels, thereby limiting vascular NO bioavailability (33-35). In addition, we found that DTT, which was present to minimize mechanism-based oxidative ALDH inactivation, caused rapid consumption of authentic (DEA/NO-derived) NO that was prevented by superoxide dismutase.4 This apparent superoxide generation may be due to DTT autoxidation described in detail recently (36). Generation of superoxide is certainly one important factor limiting the degree of sGC activation by GTN in our experiments and may partly explain the sharply biphasic GTN concentration-response curves shown in Fig. 5. In addition, as studied in detail previously (3), oxidation of sGC-bound heme by high concentrations of GTN may counteract NO-mediated sGC activation. However, neither of these mechanisms appears to sufficiently explain limited sGC activation by a fixed concentration of GTN in the presence of increasing amounts of ALDH (Fig. 3). Because the time course of NO release from DEA/NO was not affected by addition of the proteins (data not shown), ALDH-catalyzed GTN bioactivation may have been compromised under our experimental conditions by a mechanism-based pathway that remains to be identified.
###end p 47
###begin p 48
###xml 271 273 271 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref22">22</xref>
###xml 275 277 275 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref25">25</xref>
###xml 682 683 670 671 <sub xmlns:xlink="http://www.w3.org/1999/xlink">m</sub>
###xml 681 683 669 671 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K<sub>m</sub></italic>
###xml 750 757 738 745 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="tbl1">Table 1</xref>
Two lines of evidence suggest that GTN bioactivation involves the catalytic site of ALDH. First, GTN-triggered sGC activation and NO formation were blocked by established substrate-competitive ALDH inhibitors. In line with the known selectivity profile of the compounds (22, 25), chloral hydrate attenuated GTN bioactivation by both ALDH1 and ALDH2, whereas daidzin selectively interfered with the ALDH2-catalyzed reaction. Second, GTN concentration-response curves revealed an approximately10-fold higher potency of the nitrate to activate sGC in the presence of ALDH2 than with ALDH1. This difference in the apparent GTN binding affinities is in line with the differences in the Km values of the two isoforms for aldehyde and ester substrates (see Table 1).
###end p 48
###begin p 49
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">SCHEME 1.</label>
###xml 9 71 9 71 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="50">Hypothetical pathways of ALDH-catalyzed NO formation from GTN.</p>
###xml 9 71 9 71 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="50">Hypothetical pathways of ALDH-catalyzed NO formation from GTN.</p></caption>
###xml 71 71 71 71 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc029084218s001"/>
###xml 0 71 0 71 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig8"><label>SCHEME 1.</label><caption><p textid="50">Hypothetical pathways of ALDH-catalyzed NO formation from GTN.</p></caption><graphic xlink:href="zbc029084218s001"/></fig>
SCHEME 1.Hypothetical pathways of ALDH-catalyzed NO formation from GTN.
###end p 49
###begin p 50
Hypothetical pathways of ALDH-catalyzed NO formation from GTN.
###end p 50
###begin p 51
###xml 320 321 320 321 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 966 967 942 943 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fn" rid="fn5">5</xref>
Our data with ALDH1 unequivocally demonstrate that the catalytic conversion of GTN into 1,2- and 1,3-GDN is not a specific feature of ALDH2, suggesting a basic reaction mechanism common to both ALDH isoforms. Despite similar characteristics of ALDH1- and ALDH2-catalyzed GTN metabolism with respect to stimulation by NAD+ and preferential formation of 1,2-GDN at low GTN concentrations, there were also clear differences apparent. Besides the approximately10-fold higher GTN concentrations required for half-maximal activity of ALDH1, product distribution differed significantly between the two isoforms. In contrast to ALDH2, ALDH1 preferentially produced 1,3-GDN at saturating GTN concentrations, and the rate of 1,2-GDN formation was reduced by approximately50% at the highest GTN concentration tested. Together with preliminary findings indicating that ALDH1-catalyzed GTN metabolism is less dependent on the presence of thiols than the ALDH2-catalyzed reaction,5 these results point to subtle differences in the catalytic properties of the two isoforms. Future studies on the structure and function of wild-type and mutated ALDH isoforms should clarify the molecular basis of these differences.
###end p 51
###begin p 52
###xml 512 513 512 513 <sub xmlns:xlink="http://www.w3.org/1999/xlink">m</sub>
###xml 511 513 511 513 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K<sub>m</sub></italic>
###xml 538 540 538 540 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref17">17</xref>
###xml 579 580 579 580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref6">6</xref>
###xml 582 583 582 583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref9">9</xref>
###xml 603 605 603 605 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref10">10</xref>
###xml 742 743 742 743 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref9">9</xref>
###xml 324 332 <span type="species:ncbi:9606">patients</span>
###xml 668 671 <span type="species:ncbi:10116">rat</span>
The observation that catalysis of GTN bioactivation is not a specific feature of ALDH2 is certainly interesting with respect to ALDH enzymology, but the pharmacological relevance of this finding is unclear. The low apparent GTN affinity of ALDH1 is expected to limit the contribution of this isoform to GTN bioactivation in patients treated with therapeutically relevant low doses of the nitrate. Nevertheless, ALDH1 or other isoforms capable of catalyzing this reaction could contribute to the so-called "high Km" pathway of GTN action (17) that persists upon ALDH2 inhibition (6, 9) or gene deletion (10). Interestingly, we found that GTN bioactivation catalyzed by rat liver microsomes was sensitive to chloral hydrate but not to daidzin (9). Collectively, the currently available data suggest that ALDH1 and possibly other isoforms of the enzyme could contribute to the low affinity component of GTN action in blood vessels.
###end p 52
###begin p 53
###xml 823 827 823 827 <italic xmlns:xlink="http://www.w3.org/1999/xlink">i.e.</italic>
###xml 849 850 849 850 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1075 1077 1075 1077 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref37">37</xref>
###xml 1361 1368 1361 1368 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ</italic>
###xml 1053 1056 <span type="species:ncbi:10116">rat</span>
At present we can only speculate about the mechanism underlying the observed formation of free NO radical in the course of ALDH-catalyzed GTN metabolism. The significantly enhanced activation of sGC by inorganic nitrite in the presence of the purified ALDH isoforms shows that the enzymes are capable of converting nitrite to NO that activates sGC. Inhibition of nitrite bioactivation by chloral hydrate excludes nonspecific effects of the proteins and suggests that NO formation takes place within the catalytic sites of the enzymes. However, ALDH-mediated activation of sGC by nitrite was only partial and required extremely high nitrite concentrations, seriously questioning the relevance of this reaction for formation of GTN-derived NO. Nevertheless, because the sGC assays were performed under suboptimal conditions, i.e. in the absence of NAD+ and superoxide dismutase because of interference of these agents with the assay, the true efficiency of the reaction may be considerably higher. We are currently establishing a cGMP reporter assay with rat lung fibroblasts (37) to circumvent those limitations of the sGC assay. The high nitrite concentration that was required for ALDH-mediated sGC activation may reflect low affinity of exogenous nitrite to the catalytic site but does not exclude that GTN-derived nitrite becomes efficiently converted to NO in situ in the course of the enzymatic reaction. Thus, the available data are not sufficient to definitively rule out nitrite as an intermediate. If NO were indeed formed from GTN-derived nitrite, this could occur either via intrinsic nitrite reductase activity of ALDH or disproportionation of nitrite after protonation in the catalytic site.
###end p 53
###begin p 54
###xml 112 115 112 115 <sup xmlns:xlink="http://www.w3.org/1999/xlink">302</sup>
###xml 166 167 166 167 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
###xml 254 257 254 257 <sup xmlns:xlink="http://www.w3.org/1999/xlink">302</sup>
###xml 308 316 308 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig8" ref-type="fig">Scheme 1</xref>
###xml 771 775 771 775 <italic xmlns:xlink="http://www.w3.org/1999/xlink">e.g.</italic>
###xml 794 798 794 798 <italic xmlns:xlink="http://www.w3.org/1999/xlink">e.g.</italic>
###xml 868 870 868 870 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref38">38</xref>
Preliminary data obtained with mutated ALDH2 indicate that the reactive cysteine residue in the active site (Cys302) is essential for NO formation and sGC activation.5 Therefore, the initial step of NO formation may be a nucleophilic attack of GTN at Cys302, yielding a thionitrate intermediate. As shown in Scheme 1, this intermediate could be converted to NO through two hypothetical pathways. (i) Rearrangement to a sulfenyl nitrite intermediate leads to homolysis to yield NO and sulfenyl radical. However, this pathway would result in irreversible inactivation of the enzyme after one turnover because of expected dimerization of sulfenyl radicals, and it does not explain why GTN bioactivation is triggered by free cysteine but not by cysteine-containing peptides (e.g. GSH) or proteins (e.g. BSA). (ii) Metal-catalyzed reaction of the thionitrate intermediate (38) with an adjacent cysteine residue would result in formation of NO and a disulfide. This pathway accommodates reversible inactivation of ALDH2 by GTN as well as the inactivity of proteins not containing vicinal cysteine residues in appropriate conformation, but the lack of effect of diethylenetriaminepentaacetic acid argues against the involvement of a redox-active trace metal. However, further work with various metal chelators is required to definitively settle this issue.
###end p 54
###begin p 55
###xml 162 164 162 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref39">39</xref>
###xml 335 337 335 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref40">40</xref>
It has been shown that vascular GTN metabolism results in production of hydroxylamine, suggesting that HNO may be formed as an intermediate of GTN bioactivation (39). The NO-like properties of HNO donors such as Angeli's salt may be explained by 1-electron oxidation of nitroxyl to NO by superoxide dismutase or transition metal ions (40). Although the trace metal chelator diethylenetriaminepentaacetic acid had no significant effect on GTN-triggered sGC activation, and the purified ALDH proteins did not contain significant amounts of bound trace metals, we cannot rule out HNO as an intermediate of GTN bioactivation.
###end p 55
###begin p 56
###xml 205 212 205 212 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 350 351 350 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref9">9</xref>
###xml 533 540 533 540 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
Taken together, the present results demonstrate that ALDH1 and ALDH2 convert GTN into significant amounts of NO. It is hard to judge whether this direct formation of NO explains GTN-induced cGMP formation in vivo. Of note, we found that <5% of maximal (NO-stimulated) cGMP accumulation in blood vessels is sufficient for maximal vascular relaxation (9). Therefore, suboptimal activation of sGC by GTN as observed here in the presence of purified ALDH isoforms may fully account for the ALDH-dependent vascular effects of the nitrate in vivo. Nevertheless, we cannot exclude the existence of additional pathways linking ALDH-catalyzed GTN metabolism to sGC activation in vascular smooth muscle cells. Further studies are warranted to clarify the biological relevance of our findings and the molecular mechanism underlying ALDH-catalyzed NO formation.
###end p 56
###begin p 57
###xml 191 192 191 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 78 84 <span type="species:ncbi:9913">bovine</span>
The abbreviations used are: GTN, nitroglycerin; GDN, glycerol dinitrate; BSA, bovine serum albumin; DEA/NO, 2,2-diethyl-1-nitroso-oxyhydrazine; DTT, dithiothreitol; GSH, glutathione; MES, 2-(N-morpholino)ethanesulfonic acid; ODQ, 1H-[1,2,4]oxadiazolo[4,3-alpha]quinoxalin-1-one; sGC, soluble guanylate cyclase.
###end p 57
###begin p 58
A. Kollau, M. Beretta, M. Russwurm, D. Koesling, W. M. Keung, K. Schmidt, and B. Mayer, submitted for publication.
###end p 58
###begin p 59
K. Schmidt and B. Mayer, unpublished observations.
###end p 59
###begin p 60
M. Beretta, W. M. Keung, and B. Mayer, unpublished observations.
###end p 60

